Filing Details
- Accession Number:
- 0001127602-19-003741
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-02-04 16:17:49
- Reporting Period:
- 2019-02-01
- Accepted Time:
- 2019-02-04 16:17:49
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 64803 | Cvs Health Corp | CVS | Retail-Drug Stores And Proprietary Stores (5912) | 050494040 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1194413 | J Larry Merlo | One Cvs Drive Woonsocket RI 02895- | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-02-01 | 166,368 | $45.07 | 496,577 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-02-01 | 166,368 | $64.51 | 330,209 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option | Disposition | 2019-02-01 | 166,368 | $0.00 | 166,368 | $45.07 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2013-04-02 | 2019-04-02 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 378,463 | Indirect | By Trust As Beneficiary |
Footnotes
- All sales were effected pursuant to a Rule 10b5-1 plan.
- Represents weighted average sale price for this group of sales, which occurred on the same trading day. Multiple sales were executed, with sales prices ranging from $62.91 and $65.29 per share.
- Option became exercisable in four equal annual installments, commencing 4/2/2013.
Billionaire Hedge Funds
